Arexvy RSV Vaccine Expansion: Broader Access an...

By HEOR Staff Writer

December 15, 2025

CHMP Backs Arexvy RSV Vaccine Expansion for All Adults 18+ The Arexvy RSV vaccine expansion has received a positive recommendation from the European Medicines Agency's Commit...
AI Governance Pharmaceuticals: Ensuring Ethical AI Integration in the Medicin...
Innovations in Haematology Cell Therapy at ASH 2025
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Res...
GLP-1RAs Psychiatric Care: Transforming Metabolic Management for Psychotropic...
NICE Endorses Obecabtagene Autoleucel Therapy for Adult Relapsed B-Cell Leuka...
Rethinking HEOR Market Access Integration: A Call for Early Engagement Before...
Patient-Reported Outcomes Trends in Clinical Trials: Insights from 2008-2023
Addressing AI Polyp Detection Gaps: A Roadmap for Evidence Generation and NHS...
Promising Advances in TNBC Treatment: Sacituzumab Govitecan in First-Line The...
Interchangeable Biosimilar Approval: FDA Greenlights Poherdy as First to Perjeta
HIV Therapy Advancements: Promising Results from Bictegravir/Lenacapavir Comb...